Serum paraoxonase 1 activity in dogs: Preanalytical and analytical factors and correlation with C-reactive protein and alpha-2-globulin

Veterinary Clinical Pathology

Volumn 42, Issue 3, 2013, Pages 329-341

  Rossi, Gabriele ^a   Giordano, Alessia ^a   Pezzia, Francesca ^a   Kjelgaard Hansen, Mads ^b   Paltrinieri, Saverio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Acute phase protein; Inflammation; Serum protein electrophoresis; Storage; Validation

Indexed keywords

CANIS FAMILIARIS;

ALPHA GLOBULIN; ARYLDIALKYLPHOSPHATASE; C REACTIVE PROTEIN;

ANIMAL; BLOOD; DOG; FEMALE; LABORATORY AUTOMATION; MALE; METABOLISM; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ALPHA-GLOBULINS; ANIMALS; ARYLDIALKYLPHOSPHATASE; AUTOMATION, LABORATORY; C-REACTIVE PROTEIN; DOGS; FEMALE; MALE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 84884206879     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/vcp.12073     Document Type: Article

References (43)

1. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high density lipoprotein (HDL) oxidation and preserves its functions: a possible peroxidative role for paraoxonase. J Clin Invest. 1998;101:1581-1590.
2. Mackness B, Hine D, Liu Y, Mastorikou M, Mackness M. Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells. Biochem Biophys Res Commun. 2004;318:680-683.
3. Watson AD, Berliner JA, Hama SY, et al. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995;96:2882-2891.
4. Van Lenten BJ, Hama SY, de Beer FC, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995;96:2758-2767.
5. Feingold KR, Memon RA, Moser AH, Grunfeld C. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis. 1998;139:307-315.
6. Cabana VG, Reardon CA, Feng N, Neath S, Lukens J, Getz GS. Serum paraoxonase: effect of the apolipoprotein composition of HDL and the acute phase response. J Lipid Res. 2003;44:780-792.
7. Kumon Y, Nakauchi Y, Kidawara K, et al. A longitudinal analysis of alteration in lecithin-cholesterol acyltransferase and paraoxonase activities following laparoscopic cholecystectomy relative to other parameters of HDL function and the acute phase response. Scand J Immunol. 1998;48:419-424.
8. Novak F, Vavrova L, Kodydkova J, et al. Decreased paraoxonase activity in critically ill patients with sepsis. Clin Exp Med. 2010;10:21-25.
9. Mackness B, Mackness MI, Durrington PN, et al. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease. Eur J Clin Invest. 2000;30:4-10.
10. Mackness B, Hine D, McElduff P, Mackness M. High C-reactive protein and low paraoxonase1 in diabetes as risk factors for coronary heart disease. Atherosclerosis. 2006;186:396-401.
11. Dirican M, Akca R, Sarandol E, Dilek K. Serum paraoxonase activity in uremic predialysis and hemodialysis patients. J Nephrol. 2004;17:813-818.
12. Boehm D, Krzystek-Korpacka M, Neubauer K, et al. Paraoxonase-1 status in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2009;15:93-99.
13. Ferré N, Camps J, Prats E, et al. Serum paraoxonase activity: a new additional test for the improved evaluation of chronic liver damage. Clin Chem. 2002;48:261-268.
14. Bionaz M, Travisi E, Calamari L, Librandi F, Ferrari A, Bretoni G. Plasma paraoxonase, health, inflammatory conditions, and liver function in transition dairy cows. J Dairy Sci. 2007;90:1740-1750.
15. Turk R, Juretic D, Geres D, et al. Serum paraoxonase activity and lipid parameters in the early postpartum period of dairy cows. Res Vet Sci. 2004;76:57-61.
16. Trevisi E, Amadori M, Bakudila AM, Bretoni G. Metabolic changes in dairy cows induced by oral, low-dose interferon-alpha treatment. J Anim Sci. 2009;87:3020-3029.
17. Motta S, Letellier C, Ropert M, Motta C, Thiébault JJ. Protecting effect of vitamin E supplementation on submaximal exercise-induced oxidative stress in sedentary dogs as assessed by erythrocyte membrane fluidity and paraoxonase-1 activity. Vet J. 2009;181:288-295.
18. Tvarijonaviciute A, Tecles F, Caldin M, Tasca S, Cerón J. Validation of spectrophotometric assays for serum paraoxonase type-1 measurement in dogs. Am J Vet Res. 2012;73:34-41.
19. Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci. 2009;46:83-106.
20. Paltrinieri S, Ravicini S, Rossi G, Roura X. Serum concentrations of the derivatives of reactive oxygen metabolites (d-ROMs) in dogs with leishmaniosis. Vet J. 2010;186(3):393-395.
21. Westgard J. Method validation. In: Westgard J, ed. Basic Method Validation. 2nd ed. Madison, WI: Westgard QC; 2003:156-157.
22. Jensen AL, Kjelgaard-Hansen M. Diagnostic test validation. In: Weiss DJ, Wardrop KJ, eds. Shalm's Veterinary Hematology. 6th ed. Iowa: Wiley-Blackwell; 2010:1027-1033.
23. Rossi S, Rossi G, Giordano A, Paltrinieri S. Homocysteine measurement by an enzymatic method and potential role of homocysteine as a biomarker in dogs. J Vet Diagn Invest. 2008;20:644-649.
24. Jacobs RM, Lumsden JH, Grift E. Effects of bilirubinemia, hemolysis, and lipemia on clinical chemistry analytes in bovine, canine, equine, and feline sera. Can Vet J. 1992;33:605-608.
25. Reference Value Advisor Macroinstructions. Available at: http://www.biostat.envt.fr/spip/spip.php?article63. Accessed February 14, 2012.
26. Geffré A, Concordet D, Braun JP, Trumel C. Reference Value Advisor: a new freeware set of macroinstructions to calculate reference intervals with Microsoft Excel. Vet Clin Pathol. 2011;40:107-112.
27. CLSI C28-A3. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2008:1-61.
28. ASVCP Quality Assurance and Laboratory Standards Committee (QALS) Guidelines for the Determination of Reference Intervals in Veterinary Species and other related topics: SCOPE. Available at: http://www.asvcp.org/pubs/pdf/RI%20Guidelines%20For%20ASVCP%20website.pdf. Accessed February 14, 2012.
29. Kjelgaard-Hansen M, Jensen AL. Subjectivity in defining quality specifications for quality control and test validation. Vet Clin Pathol. 2010;39:133-135.
30. Stockham SL, Scott MA. Fundamentals of Veterinary Clinical Pathology. 2nd ed. Ames, IA: Wiley Blackwell; 2008: 4-51.
31. Marsillach J, Aragonès G, Beltrán R, et al. The measurement of the lactonase activity of paraoxonase-1 in the clinical evaluation of patients with chronic liver impairment. Clin Biochem. 2009;42:91-98.
32. Van Himbergen TM, Van Tits LJH, Roest M, Stalenhoef AFH. The story of PON1: how an organophosphate hydrolyzing enzyme is becoming a player in cardiovascular medicine. Neth J Med. 2006;64:34-38.
33. Gaidukov L, Tawfik DS. The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity. J Lipid Res. 2007;48:1637-1646.
34. Parker JC. Passive calcium movements in dog red blood cells: anion effects. Am J Physiol. 1983;244:C318-C323.
35. Jayakumari N, Thejaseebai G. High prevalence of low serum paraoxonase-1 in subjects with coronary artery disease. J Clin Biochem Nutr. 2009;45:278-284.
36. Seres I, Paragh G, Deschene E, Fulop T Jr, Khalil A. Study of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol. 2004;39:59-66.
37. Khovidhunkit W, Memon RA, Feingold KR, Grunfeld C. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis. 2000;181:S462-S472.
38. Turk R, Juretić D, Geres D, Svetina A, Turk N, Flegar-Mestrić Z. Influence of oxidative stress and metabolic adaptation on PON1 activity and MDA level in transition dairy cows. Anim Reprod Sci. 2008;108:98-106.
39. Kjelgaard-Hansen M, Jacobsen S. Assay validation and diagnostic applications of major acute-phase protein testing in companion animals. Clin Lab Med. 2011;31:51-70.
40. Murata H, Shimada N, Yoshioka M. Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J. 2004;168:28-40.
41. Tecles F, Spiranelli E, Bonfanti U, Cerón JJ, Paltrinieri S. Preliminary studies of serum acute-phase protein concentrations in hematologic and neoplastic diseases of the dog. J Vet Intern Med. 2005;19:865-870.
42. Macdonald J, Galley HF, Webster NR. Oxidative stress and gene expression in sepsis. Br J Anaesth. 2003;90:221-232.
43. Paltrinieri S, Solano-Gallego L, Fondati A, et al. Guidelines for diagnosis and clinical classification of leishmaniasis in dogs. J Am Vet Med Assoc. 2010;236:1184-1191.